Skip to content

Comparison of Two Sedative Agents in Critically EICU Patients

Comparison of disodium phosphopropofol versus midazolam sedation in EICU patients with mechanical ventilation: A randomized controlled clinical trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125472
Enrollment
Unknown
Registered
2026-05-27
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The main disease types include respiratory failure, severe infection, trauma, shock, post-cardiac arrest, and multiple organ dysfunction.

Interventions

Control group: Midazolam injection + Remifentanil grou:Fospropofol disodium for injection + Remifentanil
Study group:Fospropofol disodium for injection + Remifentanil

Sponsors

Sichuan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years, either gender; 2. Mechanically ventilated patients admitted to the EICU requiring analgesic and sedative therapy; 3. Body mass index (BMI) 18–30 kg/m²; 4. Target analgesia: CPOT score = 0; 5. Target sedation: RASS score -3 to 0; 6. Signed informed consent obtained from the patient or legal representative;

Exclusion criteria

Exclusion criteria: 1. Participated in this or any other interventional study within the past 3 months; 2. BMI 30 kg/m²; 3. Expected survival = 0.5 µg/kg/min); 7. Use of monoamine oxidase inhibitors (MAOIs); 8. Severe liver disease (Child-Pugh Class C cirrhosis or acute liver failure); 9. Alcohol or drug intoxication; 10. History of long-term opioid use or opioid addiction; 11. Known hypersensitivity or contraindication to any study drug; 12. High-risk intestinal obstruction (including paralytic ileus); 13. Acute severe neurological disease or any condition interfering with RASS assessment; 14. Inability to provide informed consent or authorization; 15. Other conditions deemed inappropriate by the investigator;

Design outcomes

Primary

MeasureTime frame
Response Rate of Achieving Target Sedation;Wake-Up Time;

Secondary

MeasureTime frame
Duration of Mechanical Ventilation;Total Dosage of Analgesic and Sedative Drugs;General Comfort Questionnaire (GCQ) Score;EICU Hospitalization Cost;Incidence of Adverse Events;Critical Care Pain Observation Tool (CPOT) Score;In-Hospital Mortality;Richmond Agitation-Sedation Scale (RASS) Score;Length of EICU Stay;

Countries

China

Contacts

Public ContactDeng Lei

Sichuan Provincial People's Hospital

2302878419@qq.com+86 28 8739 3496

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026